A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma

Endocrine. 2000 Jun;12(3):223-6. doi: 10.1385/ENDO:12:3:223.

Abstract

We report on a patient with primary hyperparathyroidism, owing to the concurrence of parathyroid adenoma with carcinoma, who had a newly recognized germline mutation of the multiple endocrine neoplasia type 1 gene (MEN1 gene). The patient underwent total parathyroidectomy, and histological examination revealed parathyroid carcinoma and multiple adenoma of the other three glands. Genetic analysis revealed a newly recognized heterozygous germline mutation (842delC, exon 4) of the MEN1 gene. Both imaging studies and laboratory data showed no evidence of MEN1 in the patient. Four family members--three sisters and one daughter--had neither clinical features of MEN1 nor genetic evidence of the MEN1 gene. This is the first report of a germline mutation of the MEN1 gene found in a patient who exhibited the concurrence of parathyroid adenoma with carcinoma, suggesting that long-term hyperactivity of the parathyroids may result in the formation of carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / genetics*
  • Adenoma / pathology
  • Adenoma / surgery
  • Carcinoma / genetics*
  • Carcinoma / pathology
  • Carcinoma / surgery
  • Female
  • Frameshift Mutation
  • Germ-Line Mutation*
  • Heterozygote
  • Humans
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / genetics*
  • Neoplasms, Multiple Primary / genetics*
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / surgery
  • Parathyroid Neoplasms / genetics*
  • Parathyroid Neoplasms / pathology
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy
  • Pedigree